ORD TRIA

Phase 3

Active, not recruiting

• Conditions: Chronic Kidney Disease; Renal and Urogenital - Kidney disease

• Registration Number: ACTRN12605000693628
• Lead Sponsor: aunceston General Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2005-10-28
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Active, not recruiting
• Sex: All
• Target Recruitment: 200

Inclusion Criteria

Chronic Kidney Disease, Serum Creatinine >130 umol for males and >120 umol for females.GFR< 60ml/min.

Exclusion Criteria

Already taking a statinA seizure within a year of study entryHypersensitivity to atorvastatinParticipation or proposed participation in another clinical investigational study drug within 30 days.

Study & Design

• Study Type: Interventional
• Study Design: Not specified